1338 related articles for article (PubMed ID: 28943491)
1. Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study.
Veraldi GF; Mezzetto L; Macrì M; Criscenti P; Corvasce A; Poli R
Ann Vasc Surg; 2018 Feb; 47():179-187. PubMed ID: 28943491
[TBL] [Abstract][Full Text] [Related]
2. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
McQuade K; Gable D; Hohman S; Pearl G; Theune B
J Vasc Surg; 2009 Jan; 49(1):109-15, 116.e1-9; discussion 116. PubMed ID: 19028055
[TBL] [Abstract][Full Text] [Related]
3. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).
Lammer J; Zeller T; Hausegger KA; Schaefer PJ; Gschwendtner M; Mueller-Huelsbeck S; Rand T; Funovics M; Wolf F; Rastan A; Gschwandtner M; Puchner S; Ristl R; Schoder M
J Am Coll Cardiol; 2013 Oct; 62(15):1320-7. PubMed ID: 23831445
[TBL] [Abstract][Full Text] [Related]
4. Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease.
Dosluoglu HH; Cherr GS; Lall P; Harris LM; Dryjski ML
J Vasc Surg; 2008 Nov; 48(5):1166-74. PubMed ID: 18692357
[TBL] [Abstract][Full Text] [Related]
5. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
McQuade K; Gable D; Pearl G; Theune B; Black S
J Vasc Surg; 2010 Sep; 52(3):584-90; discussion 590-1, 591.e1-591.e7. PubMed ID: 20598480
[TBL] [Abstract][Full Text] [Related]
6. Heparin-bonded expanded polytetrafluoroethylene femoropopliteal bypass grafts outperform expanded polytetrafluoroethylene grafts without heparin in a long-term comparison.
Samson RH; Morales R; Showalter DP; Lepore MR; Nair DG
J Vasc Surg; 2016 Sep; 64(3):638-47. PubMed ID: 27139782
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of polytetrafluoroethylene-covered stent versus bare-metal stent in the primary treatment of severe iliac artery obstructive lesions.
Piazza M; Squizzato F; Spolverato G; Milan L; Bonvini S; Menegolo M; Grego F; Antonello M
J Vasc Surg; 2015 Nov; 62(5):1210-8.e1. PubMed ID: 26254822
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of antiplatelet/anticoagulation regimens after Viabahn stent graft treatment for femoropopliteal occlusive disease.
Ullery BW; Tran K; Itoga N; Casey K; Dalman RL; Lee JT
J Vasc Surg; 2015 Jun; 61(6):1479-88. PubMed ID: 25704407
[TBL] [Abstract][Full Text] [Related]
9. Mid-Term Outcomes of Endovascular Treatment for TASC-II D Femoropopliteal Occlusive Disease with Critical Limb Ischemia.
Torres-Blanco Á; Edo-Fleta G; Gómez-Palonés F; Molina-Nácher V; Ortiz-Monzón E
Cardiovasc Intervent Radiol; 2016 Mar; 39(3):344-52. PubMed ID: 26202389
[TBL] [Abstract][Full Text] [Related]
10. Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent.
Nguyen BN; Conrad MF; Guest JM; Hackney L; Patel VI; Kwolek CJ; Cambria RP
J Vasc Surg; 2011 Oct; 54(4):1051-1057.e1. PubMed ID: 21636240
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the standard bolia technique versus subintimal recanalization plus Viabahn stent graft in the management of femoro-popliteal occlusions.
Boufi M; Dona B; Orsini B; Auquier P; Hartung O; Alimi YS
J Vasc Surg; 2010 Nov; 52(5):1211-7. PubMed ID: 20692789
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes of endovascular treatment of TASC-II C and D femoropopliteal lesions with the Viabahn endoprosthesis.
Mohr PJ; Oyama JK; Luu JT; Stinis CT
Cardiovasc Revasc Med; 2015 Dec; 16(8):465-8. PubMed ID: 26483319
[TBL] [Abstract][Full Text] [Related]
13. Contemporary outcomes after superficial femoral artery angioplasty and stenting: the influence of TASC classification and runoff score.
Ihnat DM; Duong ST; Taylor ZC; Leon LR; Mills JL; Goshima KR; Echeverri JA; Arslan B
J Vasc Surg; 2008 May; 47(5):967-74. PubMed ID: 18372147
[TBL] [Abstract][Full Text] [Related]
14. Results for primary bypass versus primary angioplasty/stent for lower extremity chronic limb-threatening ischemia.
Darling JD; McCallum JC; Soden PA; Korepta L; Guzman RJ; Wyers MC; Hamdan AD; Schermerhorn ML
J Vasc Surg; 2017 Aug; 66(2):466-475. PubMed ID: 28274753
[TBL] [Abstract][Full Text] [Related]
15. Results of infrainguinal revascularization with bypass surgery using a heparin-bonded graft for disabling intermittent claudication due to femoropopliteal occlusive disease.
Piffaretti G; Dorigo W; Ottavi P; Pulli R; Castelli P; Pratesi C;
J Vasc Surg; 2019 Jul; 70(1):166-174.e1. PubMed ID: 31113719
[TBL] [Abstract][Full Text] [Related]
16. 1-Year Results of a Multicenter Randomized Controlled Trial Comparing Heparin-Bonded Endoluminal to Femoropopliteal Bypass.
Reijnen MMPJ; van Walraven LA; Fritschy WM; Lensvelt MMA; Zeebregts CJ; Lemson MS; Wikkeling ORM; Smeets L; Holewijn S
JACC Cardiovasc Interv; 2017 Nov; 10(22):2320-2331. PubMed ID: 29169500
[TBL] [Abstract][Full Text] [Related]
17. Iliac Artery Stenting Combined with Ipsilateral Open Femoro-Popliteal Revascularization and Its Effect on Bypass Patency.
Piazza M; Squizzato F; Lepidi S; Menegolo M; Grego F; Antonello M
Ann Vasc Surg; 2017 Oct; 44():282-288. PubMed ID: 28479462
[TBL] [Abstract][Full Text] [Related]
18. Heparin-bonded stent-graft for the treatment of TASC II C and D femoropopliteal lesions: the Viabahn-25 cm trial.
Zeller T; Peeters P; Bosiers M; Lammer J; Brechtel K; Scheinert D; Rastan A; Noory E; Beschorner U
J Endovasc Ther; 2014 Dec; 21(6):765-74. PubMed ID: 25453876
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of intravascular ultrasound in femoropopliteal stenting for peripheral artery disease with TASC II class A to C lesions.
Iida O; Takahara M; Soga Y; Suzuki K; Hirano K; Kawasaki D; Shintani Y; Suematsu N; Yamaoka T; Nanto S; Uematsu M
J Endovasc Ther; 2014 Aug; 21(4):485-92. PubMed ID: 25101575
[TBL] [Abstract][Full Text] [Related]
20. ZILVERPASS Study: ZILVER PTX Stent vs Bypass Surgery in Femoropopliteal Lesions.
Bosiers M; Setacci C; De Donato G; Torsello G; Silveira PG; Deloose K; Scheinert D; Veroux P; Hendriks J; Maene L; Keirse K; Navarro T; Callaert J; Eckstein HH; Teβarek J; Giaquinta A; Wauters J
J Endovasc Ther; 2020 Apr; 27(2):287-295. PubMed ID: 31997715
[No Abstract] [Full Text] [Related]
[Next] [New Search]